105 related articles for article (PubMed ID: 18443429)
1. Anti-ERBb4 targeted therapy combined with radiation therapy in prostate cancer. Results of in vitro and in vivo studies.
Vexler A; Lidawi G; Loew V; Barnea I; Karaush V; Lev-Ari S; Shtabsky A; Ben-Yosef R
Cancer Biol Ther; 2008 Jul; 7(7):1090-4. PubMed ID: 18443429
[TBL] [Abstract][Full Text] [Related]
2. ErbB4 targeting approaches for prostate cancer treatment.
Wheeler DL; Rangnekar VM; Schwarze SR
Cancer Biol Ther; 2008 Jul; 7(7):1095-7. PubMed ID: 18698169
[No Abstract] [Full Text] [Related]
3. Differential efficacy of combined therapy with radiation and AEE788 in high and low EGFR-expressing androgen-independent prostate tumor models.
Huamani J; Willey C; Thotala D; Niermann KJ; Reyzer M; Leavitt L; Jones C; Fleishcher A; Caprioli R; Hallahan DE; Kim DW
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):237-46. PubMed ID: 18337021
[TBL] [Abstract][Full Text] [Related]
4. Antitumor effects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies.
Baselga J; Norton L; Masui H; Pandiella A; Coplan K; Miller WH; Mendelsohn J
J Natl Cancer Inst; 1993 Aug; 85(16):1327-33. PubMed ID: 8340945
[TBL] [Abstract][Full Text] [Related]
5. In vivo therapeutic synergism of anti-epidermal growth factor receptor and anti-HER2 monoclonal antibodies against pancreatic carcinomas.
Larbouret C; Robert B; Navarro-Teulon I; Thèzenas S; Ladjemi MZ; Morisseau S; Campigna E; Bibeau F; Mach JP; Pèlegrin A; Azria D
Clin Cancer Res; 2007 Jun; 13(11):3356-62. PubMed ID: 17545543
[TBL] [Abstract][Full Text] [Related]
6. ErbB-4 may control behavior of prostate cancer cells and serve as a target for molecular therapy.
Ben-Yosef R; Starr A; Karaush V; Loew V; Lev-Ari S; Barnea I; Lidawi G; Shtabsky A; Greif Y; Yarden Y; Vexler A
Prostate; 2007 Jun; 67(8):871-80. PubMed ID: 17440944
[TBL] [Abstract][Full Text] [Related]
7. Antitumor efficacy of TRA-8 anti-DR5 monoclonal antibody alone or in combination with chemotherapy and/or radiation therapy in a human breast cancer model.
Buchsbaum DJ; Zhou T; Grizzle WE; Oliver PG; Hammond CJ; Zhang S; Carpenter M; LoBuglio AF
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3731-41. PubMed ID: 14506165
[TBL] [Abstract][Full Text] [Related]
8. Cooperative effects of adenoviral vector-mediated interleukin 12 gene therapy with radiotherapy in a preclinical model of metastatic prostate cancer.
Fujita T; Timme TL; Tabata K; Naruishi K; Kusaka N; Watanabe M; Abdelfattah E; Zhu JX; Ren C; Ren C; Yang G; Goltsov A; Wang H; Vlachaki MT; Teh BS; Butler EB; Thompson TC
Gene Ther; 2007 Feb; 14(3):227-36. PubMed ID: 17024109
[TBL] [Abstract][Full Text] [Related]
9. Effect of combining anti-epidermal growth factor receptor antibody C225 and radiation on DU145 prostate cancer.
Wagener M; Zhang X; Villarreal HG; Levy L; Allen P; Shentu S; Fang B; Krishnan S; Chang JY; Cheung MR
Oncol Rep; 2008 May; 19(5):1071-7. PubMed ID: 18425360
[TBL] [Abstract][Full Text] [Related]
10. Sodium selenite radiosensitizes hormone-refractory prostate cancer xenograft tumors but not intestinal crypt cells in vivo.
Tian J; Ning S; Knox SJ
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):230-6. PubMed ID: 20615620
[TBL] [Abstract][Full Text] [Related]
11. Ultrasound-stimulated microbubbles enhancement of fractionated radiation for tumor treatment.
Sharma D; McNabb E; Law N; Cumal A; Czarnota GJ
BMC Cancer; 2023 Jul; 23(1):693. PubMed ID: 37488490
[TBL] [Abstract][Full Text] [Related]
12. Prodrug activation gene therapy and external beam irradiation in the treatment of prostate cancer.
Atkinson G; Hall SJ
Urology; 1999 Dec; 54(6):1098-104. PubMed ID: 10604717
[TBL] [Abstract][Full Text] [Related]
13. Cooperative inhibition of renal cancer growth by anti-epidermal growth factor receptor antibody and protein kinase A antisense oligonucleotide.
Ciardiello F; Caputo R; Bianco R; Damiano V; Pomatico G; Pepe S; Bianco AR; Agrawal S; Mendelsohn J; Tortora G
J Natl Cancer Inst; 1998 Jul; 90(14):1087-94. PubMed ID: 9672257
[TBL] [Abstract][Full Text] [Related]
14. Targeting ErbB-1 and ErbB-4 in irradiated head and neck cancer: results of in vitro and in vivo studies.
Barnea I; Haif S; Keshet R; Karaush V; Lev-Ari S; Khafif A; Shtabsky A; Yarden Y; Vexler A; Ben Yosef R
Head Neck; 2013 Mar; 35(3):399-407. PubMed ID: 22367849
[TBL] [Abstract][Full Text] [Related]
15. Novel prostate cancer immunotherapy with a DNA-encoded anti-prostate-specific membrane antigen monoclonal antibody.
Muthumani K; Marnin L; Kudchodkar SB; Perales-Puchalt A; Choi H; Agarwal S; Scott VL; Reuschel EL; Zaidi FI; Duperret EK; Wise MC; Kraynyak KA; Ugen KE; Sardesai NY; Joseph Kim J; Weiner DB
Cancer Immunol Immunother; 2017 Dec; 66(12):1577-1588. PubMed ID: 28819703
[TBL] [Abstract][Full Text] [Related]
16. Treatment of cholangiocarcinoma with oncolytic herpes simplex virus combined with external beam radiation therapy.
Jarnagin WR; Zager JS; Hezel M; Stanziale SF; Adusumilli PS; Gonen M; Ebright MI; Culliford A; Gusani NJ; Fong Y
Cancer Gene Ther; 2006 Mar; 13(3):326-34. PubMed ID: 16138120
[TBL] [Abstract][Full Text] [Related]
17. Anti-tumor efficacy of an anti-epidermal-growth-factor-receptor monoclonal antibody and its F(ab')2 fragment against high- and low-EGFR-expressing carcinomas in nude mice.
Tosi E; Valota O; Negri DR; Adobati E; Mazzoni A; Meazza R; Ferrini S; Colnaghi MI; Canevari S
Int J Cancer; 1995 Sep; 62(5):643-50. PubMed ID: 7665239
[TBL] [Abstract][Full Text] [Related]
18. ERBB4 is over-expressed in human colon cancer and enhances cellular transformation.
Williams CS; Bernard JK; Demory Beckler M; Almohazey D; Washington MK; Smith JJ; Frey MR
Carcinogenesis; 2015 Jul; 36(7):710-8. PubMed ID: 25916654
[TBL] [Abstract][Full Text] [Related]
19. Radiotherapy and androgen ablation for clinically localized high-risk prostate cancer.
Pollack A; Zagars GK; Kopplin S
Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):13-20. PubMed ID: 7536720
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of combined blockade of epidermal growth factor receptor and protein kinase A.
Ciardiello F; Damiano V; Bianco R; Bianco C; Fontanini G; De Laurentiis M; De Placido S; Mendelsohn J; Bianco AR; Tortora G
J Natl Cancer Inst; 1996 Dec; 88(23):1770-6. PubMed ID: 8944008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
